Jefferies Sets $20 Price Target for Sohu.com on Strong Q3 Performance
Jefferies analyst Thomas Chong set a $20 price target for Sohu.com Limited (NASDAQ:SOHU) on November 17, 2025, suggesting a potential increase of about 27.06% from its price of $15.74 at the time. The positive outlook follows the company's recent financial performance announcement.
For the third quarter of 2025, Sohu reported total revenues of $180 million, a 19% increase year-over-year and a 43% rise from the previous quarter. The company also achieved a positive net income for the period, indicating strong financial health. According to Dr. Charles Zhang, Chairman and CEO, marketing services revenues met guidance while online game revenues and bottom-line performance exceeded expectations.
The stock was trading at approximately $15.46, an increase of 7.93% or $1.14. The day's trading range for the stock was between $14.99 and $15.92. Over the past 52 weeks, Sohu's stock has seen a high of $16.45 and a low of $7.79. The company has a market capitalization of approximately $445.5 million and a reported trading volume of 44,611 shares on the NASDAQ.
Sohu.com Limited (SOHU) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.